Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Nls Pharmaceutics Ltd announced it raised $2.94 Million in an initial filing from an offering of $2.94 Million

PUBLIC · NCELAug 24, 2026•about 4 hours ago

Amount Raised

$2.94 Million

Round Type

Seed

ZurichManufacturingBiotechnologyHealthcareHealth CareTherapeutics

Company Information

Company

NLS Pharmaceutics Ltd

Location

THE CIRCLE 6

Zurich, Zurich, Switzerland

About

NLS Pharmaceutics is a biopharmaceutical company that specializes in developing innovative therapies for patients with central nervous system disorders. The company's focus includes a diversified pipeline aimed at addressing serious unmet medical needs. It aims to improve the lives of patients through advanced drug delivery systems and small-molecule expertise.

Don't miss NLS Pharmaceutics Ltd's next move

Get an email the moment NLS Pharmaceutics Ltd raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
1 contact
Verified contactsRonen T., Executive Chairman & CEO hidden
Predictive Intelligence
Strategic

ML-powered predictions for NLS Pharmaceutics Ltd's next move

Learn about Strategic plan

NLS Pharmaceutics Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.